Domingo Francisco Javier
Díez Martínez
Investigador hasta 2021
Berlin Institute of Health
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Berlin Institute of Health (4)
2022
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331
-
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial
European Journal of Heart Failure, Vol. 24, Núm. 5, pp. 771-778
-
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial
European Journal of Heart Failure, Vol. 24, Núm. 9, pp. 1559-1568
2018
-
Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)
European Journal of Heart Failure, Vol. 20, Núm. 3, pp. 460-470